IL7 and melanoma: A single intravenous administration of a 10-μg CBD–IL-12 monotherapy and a 2-μg CBD–IL-12 + IL-7–CBD combination therapy yielded equally significant extension in the survival of B16F10 melanoma–bearing mice when compared to phosphate-buffered saline (PBS).